Skip to content
DataLookout
Menu

NCT07405268

Evaluation of the Effects of Levodopa-Benserazide Drug Combination on Periodontal Status in Patients With Parkinson's Disease

StatusCompleted
PhaseNot specified
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 4 versions: 4 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 15 words Show 6 more changesShow less
    • Trial completed
    • Primary completion date changed from estimate of Oct 10, 2026 to Oct 13, 2026
    • Study completion date changed from estimate of Nov 10, 2026 to Nov 13, 2026
    • Study description revised
    • Site details revised
    • Publications: details revised at 3 of 3 entries
  2. Minor Primary completion pushed from Aug 10, 2026 to Oct 10, 2026v3
  3. Minor Trial status changed: Not Yet Recruiting → Active, Not Recruiting
    • Study sites: 0 to 1
    v2
  4. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Salivary Inflammatory Cytokine
Timeframe: Day 1
Salivary Oxidative Stress Levels
Timeframe: Day 1

Secondary (1)

Clinical Periodontal Parameters

Arms and interventions

Parkinson's - Periodontitis

Patients diagnosed with Parkinson's Disease who also have Periodontitis.

Parkinson's - Healthy

Patients diagnosed with Parkinson's Disease who are periodontally healthy.

Control - Periodontitis

Systemically healthy participants (non-Parkinson) who have Periodontitis.

Control - Healthy

Systemically and periodontally healthy participants.

Sites

1 site in 1 country

  • Sağlık Bilimleri Üniversitesi Gülhane Diş Hekimliği FakültesiAnkara, Ankara, Turkey (Türkiye)